Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
**Background:** Long-acting somatostatin analog therapy (LA-SSA) is recommended as first-line therapy for treatment of unresectable or metastatic neuroendocrine tumors (NETs). Understanding treatment sequencing and dosing patterns of LA-SSA is essential for clinical decision-making to provide value-...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2023-12-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://jheor.org/article/89300-treatment-patterns-of-long-acting-somatostatin-analogs-for-neuroendocrine-tumors |